Preoperative chemoembolization in patients with hepatocellular carcinoma undergoing liver transplantation: Influence of emergent versus elective procedures on patient survival and tumor recurrence rate

CardioVascular and Interventional Radiology

Volumn 30, Issue 5, 2007, Pages 888-893

  Stockland, A H ^a   Walser, E M ^a   Paz Fumagalli, R ^a   McKinney, J M ^a   May, G R ^a  

^a MAYO CLINIC   (United States)

Author keywords

Hepatocelllular carcinoma; Orthotopic liver transplantation; Transarterial chemoembolization

Indexed keywords

ADULT; ARTICLE; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CHEMOEMBOLIZATION; CONTROLLED STUDY; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECURRENCE RISK; SURVIVAL RATE; SURVIVAL TIME; TUMOR NECROSIS; TUMOR RECURRENCE;

ALPHA-FETOPROTEINS; BILIRUBIN; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; EMERGENCY MEDICAL SERVICES; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIERS ESTIMATE; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NECROSIS; NEOPLASM STAGING; PREOPERATIVE CARE; PROPORTIONAL HAZARDS MODELS; RECURRENCE; SURGICAL PROCEDURES, ELECTIVE; TIME FACTORS; TREATMENT OUTCOME;

EID: 34848922378     PISSN: 01741551     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00270-007-9111-9     Document Type: Article

References (20)

1. Colombo M, de Franchis R, Del Ninno E, et al. (1991) Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med 325(10):675-680
2. Tsukuma H, Hiyama T, Tanaka S, et al. (1993) Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 328(25):1797-1801
3. Yoo HY, Patt CH, Geschwind JF, et al. (2003) The outcome of liver transplantation in patients with hepatocellular carcinoma in the United States between 1988 and 2001: 5-year survival has improved significantly with time. J Clin Oncol 21(23):4329-4335(epub 27 Oct. 2003)
4. Mazzaferro V, Regalia E, Doci R, et al. (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334:693-699
5. Llovet JM, Fuster J, Bruix J (1999) Intention-to-treat analysis of surgical treatment for early hepatocelllular carcinoma: resection versus transplantation. Hepatology 30:1434-1440
6. Bismuth H, Majno PE, Adam R (1999) Liver transplantation for hepatocellular carcinoma. Semin Liver Dis 19:311-322
7. Roayaie S, Frisher JS, Emre SH, et al. (2002) Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters. Ann Surg 235:533-539
8. Harnois DM, Steers J, Andrews JC, et al. (1999) Preoperative hepatic artery chemoembolization followed by orthotopic liver transplantation for hepatocellular carcinoma. Liver Transpl Surg 5:192-199
9. Graziadei IW, Sandmueller H, Waldenberger P, et al. (2003) Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome. Liver Transpl 9:557-563
10. Dacaens T, Roudot-Thoraval F, Bresson-Hadni S, et al. (2005) Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma. Liver Transpl 11:767-775
11. Perez SB, Meneu JC, Moreno E, et al. (2005) Is transarterial chemoembolization necessary before liver transplantation for hepatocellular carcinoma? Am J Surg 190(3):383-387
12. Ravaioli M, Grazi GL, Ercolani G, et al. (2004) Partial necrosis on hepatocellular carcinoma nodules facilitates tumor recurrence alter liver transplantation. Transplantation 78:1780-1786
13. Adachi E, Matsumata T, Nishizaki T, et al. (1993) Effects of preoperative trans-catheter hepatic arterial chemoembolization for hepatocellular carcinoma. The relationship between postoperative course and tumor necrosis. Cancer 72:3593
14. Otto G, Herber S, Heise M, et al. (2006) Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma. Liver Transpl 12:1260-1267
15. Yang SZ, Dong JH, Zhu J, et al. (2004) Detection of alpha-fetoproteins mRNA and melanoma agen-1 mRNA in peripheral blood of patients with hepatocellular carcinoma and its clinical significance. Zhonghua Wai Ke Za Zhi 42(17):1060-1063
16. Jeng KS, Sheen IS, Tsai YC (2004) Circulating messenger RNA of alpha-fetoprotein: a possible risk factor of recurrence after resection of hepatocellular carcinoma. Arch Surg 139(10):1055-1060
17. Witzigmann H, Geissler F, Benedix F, et al. (2002) Prospective evaluation of circulating hepatocytes by alpha-fetoprotein messenger RNA in patients with hepatocellular carcinoma. Surgery 131(1):34-43
18. Herber S, Schneider J, Brecher B, et al. (2005) TACE: therapy of the HCC before liver transplantation-experiences. Rofo 177(5):681-690
19. Cheng YF, Huang TL, Chen TY, et al. (2005) Impact of pre-operative transarterial embolization on the treatment of hepatocellular carcinoma with liver transplantation. World J Gastroenterol 11(10):1433-1438
20. Yao FY, Kinkhabwala M, LaBerge JM, et al. (2005) The impact of pre-operative loco-regional therapy on outcome after liver transplantation for hepatocellular carcinoma. Am J Transpl 5(4; pt 1):641-642